Skip to main content

FDA denies approval for patisiran in ATTR cardiomyopathy, despite panel nod

Primary tabs

View
Get Stamp Tags
Published Locations

Breadcrumb

Home
FDA denies approval for patisiran in ATTR cardiomyopathy, despite panel nod

User login

Username

Password

Reset your password

Concept	Lead	score
Cardiomyopathy	1	1
Amyloidosis	0	0.9
Canada	0	0.71
Interference	0	0.71

Specialty	Lead	score
Cardiology	1	1